|
QSER1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.48720000003877E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.17439999999192E-05 |
| Normal-vs-Stage2 |
1.392860E-04 |
| Normal-vs-Stage3 |
1.57983999999889E-05 |
| Normal-vs-Stage4 |
1.89301999999891E-05 |
| Stage1-vs-Stage2 |
3.220600E-01 |
| Stage1-vs-Stage3 |
2.806600E-01 |
| Stage1-vs-Stage4 |
2.187400E-01 |
| Stage2-vs-Stage3 |
8.522200E-01 |
| Stage2-vs-Stage4 |
8.723000E-01 |
| Stage3-vs-Stage4 |
7.003000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.50184999999636E-05 |
| Normal-vs-AfricanAmerican |
5.163800E-02 |
| Normal-vs-Asian |
6.24860000000282E-05 |
| Caucasian-vs-AfricanAmerican |
4.137000E-01 |
| Caucasian-vs-Asian |
4.708000E-01 |
| AfricanAmerican-vs-Asian |
2.384000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.70390000004051E-07 |
| Normal-vs-Female |
2.21779999999283E-05 |
| Male-vs-Female |
1.804600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.433100E-04 |
| Normal-vs-Age(41-60Yrs) |
1.49270000004975E-06 |
| Normal-vs-Age(61-80Yrs) |
1.92104999999776E-05 |
| Normal-vs-Age(81-100Yrs) |
2.935200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.310790E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.453040E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.442970E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.129400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.964200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.631800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.968400E-01 |
| Classical-VS-Follicular |
2.368200E-04 |
| Classical-VS-Other |
1.306440E-01 |
| Classical-VS-Normal |
4.599000E-04 |
| Tall-VS-Follicular |
2.886200E-01 |
| Tall-VS-Other |
3.450600E-01 |
| Tall-VS-Normal |
5.162600E-04 |
| Follicular-VS-Other |
7.767800E-01 |
| Follicular-VS-Normal |
4.88289999545088E-08 |
| Other-VS-Normal |
7.543200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.47360000044306E-07 |
| Normal-vs-N1 |
5.73739999999434E-05 |
| N0-vs-N1 |
8.370200E-01 |
|
|
